Critical role of cytosolic phospholipase A2α in bronchial mucus hypersecretion in CFTR-deficient mice

European Respiratory Journal

Volumn 36, Issue 5, 2010, Pages 1120-1130

  Dif, F ^a   Wu, Y Z ^a   Burgel, P R ^b   Ollero, M ^c   Leduc, D ^a   Aarbiou, J ^e   Borot, F ^c   Garcia Verdugo, I ^a   Martin, C ^b   Chignard, M ^a   Israel Biete, D ^d   Kita, Y ^f   Scholte, B J ^e   Touqui, L ^a  

^a INSTITUT PASTEUR   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c INSERM   (France)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f UNIVERSITY OF TOKYO   (Japan)

Author keywords

Arachidonic acid; Cystic fibrosis; Lipopolysaccharide; MUC5AC; Mucus; Phospholipase A2

Indexed keywords

ARACHIDONIC ACID; CYTOSOLIC PHOSPHOLIPASE A2; CYTOSOLIC PHOSPHOLIPASE A2 ALPHA; LIPOPOLYSACCHARIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRONCHUS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MOUSE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; IMMUNOHISTOCHEMISTRY; MOUSE; MUCUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ARACHIDONIC ACID; BRONCHI; CELL LINE; CHLORIDES; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; CYTOSOL; DISEASE MODELS, ANIMAL; GROUP IV PHOSPHOLIPASES A2; HUMANS; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; MICE, INBRED CFTR; MUCIN 5AC; MUCUS; RESPIRATORY MUCOSA; RNA, SMALL INTERFERING;

EID: 78349277359     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00183409     Document Type: Article

References (53)

1. Cheng SH, Gregory RJ, Marshall J, et al. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 1990; 63: 827-834. (Pubitemid 120035055)
2. Doring G, Gulbins E. Cystic fibrosis and innate immunity: how chloride channel mutations provoke lung disease. Cell Microbiol 2009; 11: 208-216.
3. Balough K, McCubbin M, Weinberger M, et al. The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis. Pediatr Pulmonol 1995; 20: 63-70.
4. Khan TZ, Wagener JS, Bost T, et al. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 1995; 151: 1075-1082.
5. Wilson JM, Collins FS. Cystic fibrosis. More from the modellers. Nature 1992; 359: 195-196.
6. Rogers DF. Airway goblet cells: responsive and adaptable frontline defenders. Eur Respir J 1994; 7: 1690-1706.
7. Rose MC. Mucins: structure, function, and role in pulmonary diseases. Am J Physiol 1992; 263: L413-L429.
8. Voynow JA. What does mucin have to do with lung disease? Paediatr Respir Rev 2002; 3: 98-103.
9. Rose MC, Voynow JA. Respiratory tract mucin genes and mucin glycoproteins in health and disease. Physiol Rev 2006; 86: 245-278.
10. Rowe SM, Miller S, Sorscher EJ. Cystic fibrosis. N Engl J Med 2005; 352: 1992-2001.
11. Dohrman A, Miyata S, Gallup M, et al. Mucin gene (MUC 2 and MUC 5AC) upregulation by Gram-positive and Gram-negative bacteria. Biochim Biophys Acta 1998; 1406: 251-259. (Pubitemid 28269307)
12. Burgel PR, Montani D, Danel C, et al. A morphometric study of mucins and small airway plugging in cystic fibrosis. Thorax 2007; 62: 153-161. (Pubitemid 46271722)
13. Groneberg DA, Eynott PR, Oates T, et al. Expression of MUC5AC and MUC5B mucins in normal and cystic fibrosis lung. Respir Med 2002; 96: 81-86.
14. Garcia MA, Yang N, Quinton PM. Normal mouse intestinal mucus release requires cystic fibrosis transmembrane regulator-dependent bicarbonate secretion. J Clin Invest 2009; 119: 2613-2622.
15. Morcillo EJ, Cortijo J. Mucus and MUC in asthma. Curr Opin Pulm Med 2006; 12: 1-6.
16. Singer M, Lefort J, Vargaftig BB. Granulocyte depletion and dexamethasone differentially modulate airways hyperreactivity, inflammation, mucus accumulation, and secretion induced by rmIL-13 or antigen. Am J Respir Cell Mol Biol 2002; 26: 74-84. (Pubitemid 34029823)
17. Rogers DF. The role of airway secretions in COPD: pathophysiology, epidemiology and pharmacotherapeutic options. COPD 2005; 2: 341-353.
18. Konstan MW, Walenga RW, Hilliard KA, et al. Leukotriene B4 markedly elevated in the epithelial lining fluid of patients with cystic fibrosis. Am Rev Respir Dis 1993; 148: 896-901.
19. Kim YD, Kwon EJ, Park DW, et al. Interleukin-1beta induces MUC2 and MUC5AC synthesis through cyclooxygenase-2 in NCI-H292 cells. Mol Pharmacol 2002; 62: 1112-1118.
20. Borot F, Vieu DL, Faure G, et al. Eicosanoid release is increased by membrane destabilization and CFTR inhibition in Calu-3 cells. PLOS One 2009; 4: e7116.
21. Ghosh M, Tucker DE, Burchett SA, et al. Properties of the Group IV phospholipase A2 family. Prog Lipid Res 2006; 45: 487-510.
22. Six DA, Dennis EA. The expanding superfamily of phospholipase A(2) enzymes: classification and characterization. Biochim Biophys Acta 2000; 1488: 1-19.
23. Peters-Golden M, Canetti C, Mancuso P, et al. Leukotrienes: under-appreciated mediators of innate immune responses. J Immunol 2005; 174: 589-594. (Pubitemid 40103563)
24. Tilley SL, Coffman TM, Koller BH. Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J Clin Invest 2001; 108: 15-23.
25. Bonventre JV, Huang Z, Taheri MR, et al. Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2. Nature 1997; 390: 622-625. (Pubitemid 28016198)
26. Nagase T, Uozumi N, Ishii S, et al. A pivotal role of cytosolic phospholipase A(2) in bleomycin-induced pulmonary fibrosis. Nat Med 2002; 8: 480-484.
27. Uozumi N, Kume K, Nagase T, et al. Role of cytosolic phospholipase A2 in allergic response and parturition. Nature 1997; 390: 618-622. (Pubitemid 28016197)
28. Snouwaert JN, Brigman KK, Latour AM, et al. An animal model for cystic fibrosis made by gene targeting. Science 1992; 257: 1083-1088.
29. Nagase T, Uozumi N, Aoki-Nagase T, et al. A potent inhibitor of cytosolic phospholipase A2, arachidonyl trifluoromethyl ketone, attenuates LPS-induced lung injury in mice. Am J Physiol Lung Cell Mol Physiol 2003; 284: L720-L726. (Pubitemid 36459017)
30. Chignard M, Balloy V. Neutrophil recruitment and increased permeability during acute lung injury induced by lipopolysaccharide. Am J Physiol Lung Cell Mol Physiol 2000; 279: L1083-L1090. (Pubitemid 32009494)
31. Haile S, Lefort J, Joseph D, et al. Mucous-cell metaplasia and inflammatory-cell recruitment are dissociated in allergic mice after antibody- and drug-dependent cell depletion in a murine model of asthma. Am J Respir Cell Mol Biol 1999; 20: 891-902. (Pubitemid 129540848)
32. Yanagihara K, Seki M, Cheng PW. Lipopolysaccharide induces mucus cell metaplasia in mouse lung. Am J Respir Cell Mol Biol 2001; 24: 66-73.
33. Burgel PR, Lazarus SC, Tam DC, et al. Human eosinophils induce mucin production in airway epithelial cells via epidermal growth factor receptor activation. J Immunol 2001; 167: 5948-5954.
34. Filgueiras OM, Possmayer F. Characterization of phospholipase A2 from rabbit lung microsomes. Lipids 1987; 22: 731-735.
35. Hidi R, Vargaftig BB, Touqui L. Increased synthesis and secretion of a 14-kDa phospholipase A2 by guinea pig alveolar macrophages. Dissociation from arachidonic acid liberation and modulation by dexamethasone. J Immunol 1993; 151: 5613-5623.
36. -/- knockout mice. Metabolism 2006; 55: 1192-1200.
37. Kohri K, Ueki IF, Nadel JA. Neutrophil elastase induces mucin production by ligand-dependent epidermal growth factor receptor activation. Am J Physiol Lung Cell Mol Physiol 2002; 283: L531-L540.
38. Burgel PR, Nadel JA. Roles of epidermal growth factor receptor activation in epithelial cell repair and mucin production in airway epithelium. Thorax 2004; 59: 992-996.
39. Perez A, Issler AC, Cotton CU, et al. CFTR inhibition mimics the cystic fibrosis inflammatory profile. Am J Physiol Lung Cell Mol Physiol 2007; 292: L383-395.
40. Okamoto K, Kim JS, Rubin BK. Secretory phospholipases A2 stimulate mucus secretion, induce airway inflammation, and produce secretory hyperresponsiveness to neutrophil elastase in ferret trachea. Am J Physiol Lung Cell Mol Physiol 2007; 292: L62-L67.
41. Davidson DJ, Dorin JR, McLachlan G, et al. Lung disease in the cystic fibrosis mouse exposed to bacterial pathogens. Nat Genet 1995; 9: 351-357.
42. Cressman VL, Hicks EM, Funkhouser WK, et al. The relationship of chronic mucin secretion to airway disease in normal and CFTR-deficient mice. Am J Respir Cell Mol Biol 1998; 19: 853-866.
43. Berguerand M, Klapisz E, Thomas G, et al. Differential stimulation of cytosolic phospholipase A2 by bradykinin in human cystic fibrosis cell lines. Am J Respir Cell Mol Biol 1997; 17: 481-490.
44. 2+-induced arachidonic acid release by epithelial cells. DNA Cell Biol 1997; 16: 749-759.
45. Chap H. Une homologie frappante entre CFTR et les annexines [A striking homology between CFTR and annexins]. Médecine/Science 1991; 7: 8-9.
46. Flower RJ, Rothwell NJ. Lipocortin-1: cellular mechanisms and clinical relevance. Trends Pharmacol Sci 1994; 15: 71-76.
47. Kim S, Ko J, Kim JH, et al. Differential effects of annexins I, II, III, and V on cytosolic phospholipase A2 activity: specific interaction model. FEBS Lett 2001; 489: 243-248.
48. Engelhardt JF, Yankaskas JR, Ernst SA, et al. Submucosal glands are the predominant site of CFTR expression in the human bronchus. Nat Genet 1992; 2: 240-248.
49. Lukacs GL, Mohamed A, Kartner N, et al. Conformational maturation of CFTR but not its mutant counterpart (Δ F508) occurs in the endoplasmic reticulum and requires ATP. Embo J 1994; 13: 6076-6086.
50. Borthwick LA, McGaw J, Conner G, et al. The formation of the cAMP/protein kinase A-dependent annexin 2-S100A10 complex with cystic fibrosis conductance regulator protein (CFTR) regulates CFTR channel function. Mol Biol Cell 2007; 18: 3388-3397.
51. Trouve P, Le Drevo MA, Kerbiriou M, et al. Annexin V is directly involved in cystic fibrosis transmembrane conductance regulator's chloride channel function. Biochim Biophys Acta 2007; 1772: 1121-1133.
52. Chung YW, Oh HY, Kim JY, et al. Allergen-induced proteolytic cleavage of annexin-1 and activation of cytosolic phospholipase A2 in the lungs of a mouse model of asthma. Proteomics 2004; 4: 3328-3334.
53. Bensalem N, Ventura AP, Vallee B, et al. Down-regulation of the anti-inflammatory protein annexin A1 in cystic fibrosis knock-out mice and patients. Mol Cell Proteomics 2005; 4: 1591-1601. (Pubitemid 41555482)